MedTrace Logo

C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.

NCT04935515 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-06-23

No results posted yet for this study

Summary

During the peak of the second COVID -19 wave, the hospitals were over-crowded. Many COVID -19 positive patients had to stay at home and reach out to their family physicians for guidance. Medical follow-up for these patients was a daunting challenge. As in - patient hospital facilities were not readily accessible due to over crowding, early objective tests to identify home quarantined patients prone to deterioration and timely medical intervention to avoid hospitalization were required.

Based on early assessment of inflammatory markers like CRP and clinical signs like persistent high-grade fever, need-based early medical intervention was initiated in home quarantined COVID -19 patients prior to the onset of hypoxia, in order to avoid complications and hospitalization

Conditions

  • COVID -19

Interventions

DRUG

Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins

Oral Azithromycin , Cetirizine, Paracetamol, Zinc, Vitamin C, Vitamin D

DRUG

Oral low dose steroid

Low dose oral methyl prednisolone was added.

DRUG

Intravenous Antibiotics with Low dose steroid.

Intravenous ceftriaxone with either oral methyl prednisolone or intravenous dexamethasone was given

DRUG

Oral anti-coagulant

Rivaroxaban was given for minimum 4 weeks depending on D dimer levels

Sponsors & Collaborators

  • UR Anoop Research Group

    collaborator OTHER

  • Manimarane Arjunan, MD,DM (Cardiology)

    lead OTHER

Principal Investigators

  • MANIMARANE ARJUNAN, MD,DM-CARDIO · UR Anoop Research Group

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2021-05-09
Completion
2021-06-06

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04935515 on ClinicalTrials.gov